Prodrug for tumor therapy

The world market for cancer diagnosis is estimated to be 3.5 billion dollars for 2010. Scientists at the University of Goettingen identified a new diagnostic tumor marker, which shows a general recognition of almost all cancers, an early detection of tumors and a very close causative link to cancer development. Thus, in the nearby future, this marker could also be used as a target for cancer therapy, as seen in first proof of principle experiments. The use in diagnostics of this new tumor marker would be ideal for first line of regular screening and for monitoring of a cancer therapy.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Combatting disruptive ‘noise’ in quantum communication

In a significant milestone for quantum communication technology, an experiment has demonstrated how networks can be leveraged to combat disruptive ‘noise’ in quantum communications. The international effort led by researchers…

Stretchable quantum dot display

Intrinsically stretchable quantum dot-based light-emitting diodes achieved record-breaking performance. A team of South Korean scientists led by Professor KIM Dae-Hyeong of the Center for Nanoparticle Research within the Institute for…

Internet can achieve quantum speed with light saved as sound

Researchers at the University of Copenhagen’s Niels Bohr Institute have developed a new way to create quantum memory: A small drum can store data sent with light in its sonic…

Partners & Sponsors